Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Open in API
Filings indexed 1,395 across all filing types
Latest filing 2025-08-06 Regulatory Filings
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-08-06 English
Regulatory Filings 2025
Regulatory Filings
2025-08-06 English
10-Q
Interim / Quarterly Report Q2 2025
2025-08-04 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC by IDEXX Laboratories, Inc. dated August 4, 2025. It announces the company's financial results for the quarter ended June 30, 2025, and includes a press release titled "IDEXX Laboratories Announces Second Quarter Results." The document explicitly states it is a Current Report on Form 8-K, which is used for unscheduled material events or corporate changes. The content is a financial results announcement for a quarter, which aligns with an Earnings Release (ER). The document is about 4,521 characters, which is relatively short and consistent with a Form 8-K earnings announcement rather than a full interim report. Therefore, the correct classification is Earnings Release (ER).
2025-08-04 English
FORM 3
Director's Dealing
2025-07-18 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated July 10, 2025, by IDEXX Laboratories, Inc. The key content is the election of a new director, Joseph L. (Jay) Hooley, to the board, including details about his appointment and compensation. The document does not contain financial statements or earnings data but focuses on a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 6080 characters, which is sufficient to contain substantive information about the board change, not just a brief announcement or a report publication notice. Therefore, the correct classification is MANG with high confidence.
2025-07-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.